1Bhatla N, Dar L, Rajkumar Patro A,et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India [ J ]. Int J Gynecol Pathol, 2008,27 : 426430.
2Hamlin-Douglas LK, Coutlee F, Roger M, et al. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec [ J ]. Cancer Epidemiol Biomarkers Prey, 2008,17 : 3141 - 3149.
3Sandri MT, Riggio D, Salvatici M, et al. Typing of human papillomavirus in women with cervical lesions:prevalence and distribution of different genotypes [ J]. J Med Virol, 2009,81:271-277.
6Li W,Wang W,Si M,et al. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma[J]. J Cancer Res Clin Oncol ,2008,134 : 1355-1361.
7Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia[ J]. Cancer Epidemiol Biomarkers Prey,2006, 15 : 1274-1280.
8Wu Y, Chen Y, Li L, et al. Associations of high-risk HPV types and viral load with cervical cancer in China [ J ]. J Clin Virol, 2006,35 : 264-269.
9Arbyn M, Benoy I, Simoens C, et al. Prevaccination distribution of human papillomavims types in women attending at cervical cancer screening in Belgium [ J ]. Cancer Epidemiol Biomarkers Prev ,2009,18:321-330.
10Mejlhede N, Bonde J, Fomsgaard A. High frequency of multiple HPV types in cervical specimens from Danish women [ J ]. APMIS ,2009,117 : 108-114.
二级参考文献17
1Huang S,Afonina I,Miller BA,et al.Huamn papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women.Int J Cancer,1997,73:775-776.
2Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis.Br J Cancer,2003,88:63-73.
3McLachlin CM.Human Papillomavirus in cervical neroplasia.Role,risk factors and implications.Clin Lab Med,2000,20:257-270.
4Masumoto N,Fujii T,Ishikawa M,et al.Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women;study of 881 outpatients.Gynecol Oncol,2004,94:509-514.
5Stanczuk GA,Kay P,Sibanda E,et al.Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix.Acta Obstet Gynecol Scand,2003,82:762-766.
6Poljak M,Marin IJ,Seme K,et al.Hybrid Capture Ⅱ Test detects at lease 15 human papillomvirus genotypes not included in its current high-risk probe cocktail.J Clin Virol,2002,25:S89-S97.
7Dell G,Gaston K.Human papillomaviruses and their role in cervical cancer.Cell Mol Life Sci,2001,58:1923-1942.
8Lo KW,Wong YF,Chan MK,et al.Prevalence of human papillomavirus in cervical cancer:a multicenter study in China.Int J Cancer,2002,100:327-331.
9Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:implications for screening and prevention[ J]. J Natl Cancer Inst,2006,98:303-315.
10Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[ J]. N Engl J Med,2003,348:518- 527
7de Cremoux P, de la Rochefordi6re A, Savignoni A, et al. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype[J]. Int J Cancer, 2009,124(4) :778-782.
8Li W, Wang W, Si M, et al. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma[J]. J Cancer Res Clin Oncol, 2008, 134,1355-1361.
9Chan PK,Chang AR, Yu MY, etal. Age distribution of hu- man papillomavirus infection and cervical neoplasia reflects caveats of cervical screenimg policies[J]. Int J Cancer,2010, 126(1) :297-301.
